Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Transplantation and Cellular Therapy|November 3, 2024
Representativeness of Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Trial ParticipantsManmeet Kaur, Mary M Horowitz, Adam Mendizabal, et al.
Cancer Medicine|January 29, 2026
Trends in US Hematology/Oncology Physician Perceptions and Referral Practices for Hematopoietic Cell Transplant: A National Survey Conducted by NMDPAye Mon Thida, Ankita Shah, Kelley Frederick Steffens, et al.
Transplantation and Cellular Therapy|September 20, 2021
Return-to-School Practices for Pediatric Hematopoietic Cell Transplantation Recipients during the COVID-19 PandemicNeel S Bhatt, Christa Meyer, Lih-Wen Mau, et al.
Transplantation and Cellular Therapy|July 5, 2021
Barriers to Access to Hematopoietic Cell Transplantation among Patients with Acute Myeloid Leukemia in VirginiaJoseph Mock, Christa Meyer, Lih-Wen Mau, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 16, 2020
Myeloablative versus Reduced-Intensity Hematopoietic Cell Transplantation in Myelodysplastic Syndromes: Systematic Review and Meta-analysisArmin Rashidi, Mohamad A Meybodi, Wenhao Cao, et al.
British Journal of Haematology|June 11, 2015
Lenalidomide and vorinostat maintenance after autologous transplant in multiple myelomaDouglas W Sborov, Don M Benson, Nita Williams, et al.
Transfusion|January 10, 2006
Granulocyte-colony-stimulating factor-mobilized prophylactic granulocyte transfusions given after allogeneic peripheral blood progenitor cell transplantation result in a modest reduction of febrile days and intravenous antibiotic usageAarti Oza, Chris Hallemeier, Lawrence Goodnough, et al.
British Journal of Haematology|September 27, 2003
Long-term outcomes of allogeneic stem cell transplant recipients after calcineurin inhibitor-induced neurotoxicityRizwana Chohan, Ravi Vij, Douglas Adkins, et al.
British Journal of Haematology|October 2, 2014
Results of a prospective multicentre myeloablative double-unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasiaJuliet N Barker, Mingwei Fei, Chatchada Karanes, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 9, 2020
Priorities for Improving Outcomes for Nonmalignant Blood Diseases: A Report from the Blood and Marrow Transplant Clinical Trials NetworkJohn E Levine, Joseph H Antin, Carl E Allen, et al.
Pageof 8